2021
DOI: 10.1186/s12889-021-11051-w
|View full text |Cite
|
Sign up to set email alerts
|

A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity

Abstract: Background Cardiovascular disease (CVD), one of the most common comorbidities of coronavirus disease 2019 (COVID-19), has been suspected to be associated with adverse outcomes in COVID-19 patients, but their correlation remains controversial. Method This is a quantitative meta-analysis on the basis of adjusted effect estimates. PubMed, Web of Science, MedRxiv, Scopus, Elsevier ScienceDirect, Cochrane Library and EMBASE were searched comprehensively… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
39
0
2

Year Published

2022
2022
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(45 citation statements)
references
References 208 publications
3
39
0
2
Order By: Relevance
“…In line with these meta-analyses, our study identified that hypertension, cardiovascular disease, diabetes, and obesity were the most prevalent among COVID-19 patients. Moreover, compared with the discharged COVID-19 patients, nondischarged patients were more likely to have three or more comorbidities, which is consistent with other previous results showing that patients with multiple morbidities are at the highest risk of developing complications leading to death [73,74].…”
Section: Discussionsupporting
confidence: 90%
“…In line with these meta-analyses, our study identified that hypertension, cardiovascular disease, diabetes, and obesity were the most prevalent among COVID-19 patients. Moreover, compared with the discharged COVID-19 patients, nondischarged patients were more likely to have three or more comorbidities, which is consistent with other previous results showing that patients with multiple morbidities are at the highest risk of developing complications leading to death [73,74].…”
Section: Discussionsupporting
confidence: 90%
“…Unfortunately, comparisons with national trends is limited because data on age dis-tributions in the early pandemic period (January-April 2020) were excluded from national reports because of inconsistent COVID-19 testing availability (Boehmer et al, 2020). However, this sample reflected broader national norms in terms of prevalence of comorbidities such as heart conditions and obesity that have been shown to contribute to the severity of COVID-19 (Simonnet et al, 2020;Xu et al, 2021). Much of the sample resided in geographic areas that are largely comprised of people from diverse racial and ethnic backgrounds, including several minority/majority areas.…”
Section: Key Resultsmentioning
confidence: 99%
“…In the elderly population, we saw that multimorbidity networks with metabolic and cardiovascular diseases had the highest risk of COVID-19 hospitalization and mortality. Cardiovascular comorbidity has been associated with poorer prognosis in SARS-CoV-2 infected individuals, and many authors have suggested that people with preexisting cardiovascular diseases may need special attention [ 12 , 13 , 14 , 55 ]. In the general population, especially in the elderly, a cardiorespiratory pattern has been identified; the association between cardiovascular and pulmonary diseases is well known in the literature and of great importance in clinical practice [ 18 , 56 ].…”
Section: Discussionmentioning
confidence: 99%